In human ovarian cancer cells, it inhibits the expression of VEGF and HIF1 through the pI3K/AKT/p70S6K1 and homologue of mdm2 (HDM2)/p53 pathways, inducing a mitochondrial death cascade. This evidence concerns the gene MDM2 and ovarian carcinoma.